These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8049611)

  • 1. Drug abuse screening with immunoassays: unexpected cross-reactivities and other pitfalls.
    Colbert DL
    Br J Biomed Sci; 1994 Jun; 51(2):136-46. PubMed ID: 8049611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests.
    Musshoff F; Driever F; Lachenmeier K; Lachenmeier DW; Banger M; Madea B
    Forensic Sci Int; 2006 Jan; 156(2-3):118-23. PubMed ID: 16410161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick".
    Biermann T; Schwarze B; Zedler B; Betz P
    Forensic Sci Int; 2004 Jun; 143(1):21-5. PubMed ID: 15177627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Triage screening for drugs of abuse in postmortem blood and urine samples.
    Moriya F; Hashimoto Y
    Nihon Hoigaku Zasshi; 1997 Jun; 51(3):214-9. PubMed ID: 9301227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the Cozart RapiScan system as an on-site screening tool for drugs of abuse in a non-conventional biological matrix: vitreous humor.
    Fucci N; De Giovanni N; De Giorgio F; Liddi R; Chiarotti M
    Forensic Sci Int; 2006 Jan; 156(2-3):102-5. PubMed ID: 16410159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the Triage panel for drugs of abuse to forensic blood samples.
    Moriya F; Hashimoto Y
    Nihon Hoigaku Zasshi; 1996 Apr; 50(2):50-6. PubMed ID: 8691649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium.
    Montgomery D; Plate C; Alder SC; Jones M; Jones J; Christensen RD
    J Perinatol; 2006 Jan; 26(1):11-4. PubMed ID: 16281047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity studies and predictive modeling of "Bath Salts" and other amphetamine-type stimulants with amphetamine screening immunoassays.
    Petrie M; Lynch KL; Ekins S; Chang JS; Goetz RJ; Wu AH; Krasowski MD
    Clin Toxicol (Phila); 2013 Feb; 51(2):83-91. PubMed ID: 23387345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-positive urine opiate screening associated with fluoroquinolone use.
    Zacher JL; Givone DM
    Ann Pharmacother; 2004 Sep; 38(9):1525-8. PubMed ID: 15252190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France).
    Labat L; Fontaine B; Delzenne C; Doublet A; Marek MC; Tellier D; Tonneau M; Lhermitte M; Frimat P
    Forensic Sci Int; 2008 Jan; 174(2-3):90-4. PubMed ID: 17418990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-positive interferences of common urine drug screen immunoassays: a review.
    Saitman A; Park HD; Fitzgerald RL
    J Anal Toxicol; 2014 Sep; 38(7):387-96. PubMed ID: 24986836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls in industrial drug screening.
    Adams J
    J Miss State Med Assoc; 1998 Jun; 39(6):214-7. PubMed ID: 9635387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid urine drug screens: diphenhydramine and methadone cross-reactivity.
    Rogers SC; Pruitt CW; Crouch DJ; Caravati EM
    Pediatr Emerg Care; 2010 Sep; 26(9):665-6. PubMed ID: 20838187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.
    Stout PR; Klette KL; Horn CK
    J Forensic Sci; 2004 Jan; 49(1):160-4. PubMed ID: 14979364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.